Brian Gallagher, Jr has left SR One after eight years as a partner, setting up a Boston office on the way, to join Abingworth.
Month: October 2018
Vision Fund plots course to Zuoyebang investment
SoftBank Vision Fund is in discussions to invest some $500m in the online educational assistance platform, which was spun off from Baidu three years ago.
Miniso minds cash reserves with $146m
Tencent joined Hillhouse Capital to make an equity investment in fast fashion retailer Miniso as the latter continues to expand internationally.
JHL assimilates cash at $750m valuation
Cancer biosimilar developer JHL Biotech raised an undisclosed sum in a Sanofi-backed round as it prepares to re-list on a stock exchange, this time choosing Hong Kong.
Liulishuo passes IPO exam
Liulishuo has listed on the New York Stock Exchange following a $71.9m initial public offering that provided an exit to publishing house Hearst.
KSQ takes $80m in series C round
Lilly Asia Ventures and existing backer Alexandria Real Estate Equities helped the cancer immunotherapy developer add $80m to the $76m it closed last year.
Gritstone rocks $100m IPO
The Eli Lilly-backed immuno-oncology product developer floated at the top of its range, with Bluebird Bio investing $10m.
Nozomi looks to Energize in $30m series C
Industrial cybersecurity software provider Nozomi Networks took its overall funding to almost $54m in a round featuring Invenergy-backed Energize.
Udesk works out series C funding
The customer service platform developer raised $43.5m in a Legend Capital-backed round that took its total funding to approximately $66m.
Pymetrics picks out corporates to raise $40m
Recruitment analytics technology provider Pymetrics has closed a series B round featuring Salesforce Ventures and returning investor Workday Ventures.
GV pays another visit to Veem in $25m round
Existing backer GV returned to reinvest in cross-border payment platform Veem as part of a round led by Goldman Sachs.
Attn attends to series C with $15m
The short-form video producer has received $15m from existing investor Evolution Media as it prepares to grow its television content
Seabuy sees Taofen8 in series A round
The cross-border e-commerce platform raised $14.6m in a Taofen8-led round that included Santuo Investment Management and Ningbo Municipal Government Angel Guidance Fund.
Sutro seals $86m IPO
Immunotherapy developer Sutro Biopharma has floated on the Nasdaq Global Market, providing exits for Merck & Co, Celgene, Amgen and Eli Lilly.